Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supreme Court Closes Term With Actions On Several Pharma Cases, Including Universities' Rights Under Bayh-Dole

This article was originally published in The Pink Sheet Daily

Executive Summary

The court's orders address Stanford University's suit against Roche Molecular, Pfizer's petition to review Trovan case, and jurisdiction over antitrust claims in a patent dispute.

You may also be interested in...



Supreme Court Gets Nudge On Bayh-Dole Case; Denies HRT Petition; Will Review Infringement “State Of Mind”

The Solicitor General has urged the Supreme Court to take up a case questioning whether an inventor can eliminate a university’s rights to federally funded research by making an agreement with a third party.

Supreme Court Gets Nudge On Bayh-Dole Case; Denies HRT Petition; Will Review Infringement “State Of Mind”

The Solicitor General has urged the Supreme Court to take up a case questioning whether an inventor can eliminate a university’s rights to federally funded research by making an agreement with a third party.

Supreme Court Loosens Rule On What Processes Can Be Patented

To the relief of the biotechnology industry, the court rules in the Bilski case that a process need not be tied to a machine or transform an article to be patented.

Topics

UsernamePublicRestriction

Register

OM017175

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel